BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 5:33:00 PM | Browse: 473 | Download: 391
Publication Name World Journal of Gastroenterology
Manuscript ID 5392
Country/Territory China
Received
2013-09-04 17:15
Peer-Review Started
2013-09-05 09:18
To Make the First Decision
2013-09-27 16:55
Return for Revision
2013-09-29 10:28
Revised
2013-10-16 21:51
Second Decision
2013-11-29 10:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-30 01:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-19 19:11
Typeset the Manuscript
2013-12-30 10:21
Publish the Manuscript Online
2014-01-20 17:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
Manuscript Source Invited Manuscript
All Author List Yu Zhang, Zhi-Long Shi, Xia Yang and Zheng-Feng Yin
Funding Agency and Grant Number
Funding Agency Grant Number
China National Key Projects for Infectious Disease 2012ZX10002012-10
National High-tech R&D Program of China (863 Program) 2007AA02Z461
National Natural Science Foundation of China 30772513
National Natural Science Foundation of China 81172207
National Natural Science Foundation of China 81272669
Corresponding author Zheng-Feng Yin, MD, PhD, Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, 225 Changhai Road, Shanghai 200438, China. yinzfk@aliyun.com
Keywords Hepatocellular carcinoma; Circulating tumor cells; Recurrence and metastasis; Surgical treatment; Individualized treatment
Core Tip Circulating tumor cells (CTCs) can lead to recurrence and metastasis after surgical treatment for hepatocellular carcinoma (HCC). The development and utilization of new methods or techniques to target these cells will help reduce postoperative recurrence and metastasis and prolong the survival of HCC patients. This article proposes CTC-based strategies that provide a more comprehensive and personalized approach for the treatment of HCC. Treatment methods that incorporate multiple aspects of identification, targeting and monitoring of these tumor cells may provide more efficient and effective regimens for HCC patients undergoing radical hepatectomies.
Publish Date 2014-01-20 17:10
Citation Zhang Y, Shi ZL, Yang X, Yin ZF. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J Gastroenterol 2014; 20(1): 142-147
Url http://www.wjgnet.com/1007-9327/full/v20/i1/142.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i1.142
Full Article (PDF) WJG-20-142.pdf
Full Article (Word) WJG-20-142.doc
Manuscript File 5392-Review.doc
Answering Reviewers 5392-Answering reviewers .pdf
Copyright License Agreement 5392-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5392-Language certificate.pdf
Peer-review Report 5392-Peer review(s).pdf
Scientific Editor Work List 5392-Scientific editor work list.doc